Related Experiment Videos
Neurological complications of Mycoplasma pneumoniae infection
Abstract:
This study documents five patients with neurological disease associated with evidence of recent Mycoplasma pneumoniae infection. Four patients had encephalitis associated with coma. Two of these had hemiparesis (one with dysphasia), one had seizures, and one had cerebellar and brainstem involvement. Two also had evidence of a radiculopathy and peripheral neuropathy. One patient had aseptic meningitis with later transverse myelitis. Three patients had multiple sites of neurological involvement. Respiratory infections preceded the neurological syndromes in four cases. Antibiotic therapy did not appear to alter the course of the disease. All patients had a favourable outcome.
Insights
Recent Mycoplasma pneumoniae infection was linked to neurological disease in five patients, including encephalitis and meningitis. Despite varied symptoms and antibiotic treatment, all patients experienced a favorable outcome.
Area of Science:
- Neurology
- Infectious Diseases
Background:
- Mycoplasma pneumoniae is a common respiratory pathogen.
- Neurological complications of Mycoplasma pneumoniae infections are rare but serious.
Observation:
- This study reports on five patients presenting with diverse neurological syndromes following Mycoplasma pneumoniae infection.
- Neurological manifestations included encephalitis, aseptic meningitis, transverse myelitis, radiculopathy, and peripheral neuropathy.
Findings:
- Four patients experienced encephalitis, with symptoms ranging from coma and hemiparesis to seizures and brainstem involvement.
- Three patients exhibited multiple neurological sites of involvement, and respiratory symptoms preceded neurological onset in four cases.
- Antibiotic therapy did not influence disease progression, yet all patients achieved a positive recovery.
Implications:
- Mycoplasma pneumoniae should be considered in the differential diagnosis of acute neurological disorders.
- Early recognition and supportive care are crucial for managing these rare neurological complications.
- Further research is needed to understand the pathogenesis and optimize treatment strategies for neuro-Mycoplasma pneumoniae infections.